AIM
ELV icon

Artemis Investment Management’s Elevance Health ELV Stock Holding History

Artemis Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,290
Closed -$8.59M – 208
2024
Q4 		$8.59M Sell
23,290
-166,974
-88% -$69.9M 0.12% 148
2024
Q3 		$98.9M Sell
190,264
-24,352
-11% -$13M 1.51% 11
2024
Q2 		$116M Buy
214,616
+130,859
+156% +$69.2M 1.56% 12
2024
Q1 		$43.4M Buy
83,757
+11,627
+16% +$5.78M 0.55% 60
2023
Q4 		$34M Buy
72,130
+10,683
+17% +$4.94M 0.49% 66
2023
Q3 		$26.8M Buy
61,447
+18,188
+42% +$8.25M 0.37% 78
2023
Q2 		$19.2M Sell
43,259
-105,207
-71% -$48.5M 0.24% 106
2023
Q1 		$68.1M Sell
148,466
-62,628
-30% -$29.8M 0.83% 34
2022
Q4 		$109M Sell
211,094
-183,542
-47% -$93.2M 1.23% 24
2022
Q3 		$180M Buy
394,636
+39,554
+11% +$18.9M 2.05% 6
2022
Q2 		$172M Sell
355,082
-192,551
-35% -$95.3M 1.77% 9
2022
Q1 		$268M Buy
547,633
+101,244
+23% +$46.3M 2.15% 5
2021
Q4 		$207M Buy
446,389
+59,956
+16% +$25.2M 1.5% 13
2021
Q3 		$144M Buy
386,433
+278,044
+257% +$106M 1.14% 20
2021
Q2 		$41.4M Sell
108,389
-62
-0.1% -$23.7K 0.36% 89
2021
Q1 		$38.9M Sell
108,451
-214,836
-66% -$69.1M 0.37% 86
2020
Q4 		$104M Buy
323,287
+268,527
+490% +$82.4M 1.09% 20
2020
Q3 		$14.7M Sell
54,760
-146,057
-73% -$39.3M 0.18% 150
2020
Q2 		$52.9M Buy
200,817
+80,510
+67% +$21.5M 0.71% 39
2020
Q1 		$27.3K Sell
120,307
-248,842
-67% -$67.8M 0.05% 59
2019
Q4 		$111M Buy
369,149
+7,436
+2% +$2.05M 1.41% 11
2019
Q3 		$86.7M Buy
361,713
+40,400
+13% +$11.1M 1.18% 19
2019
Q2 		$90.4M Buy
321,313
+20,084
+7% +$5.49M 1.07% 21
2019
Q1 		$86.5M Sell
301,229
-63,349
-17% -$18.3M 1.01% 24
2018
Q4 		$95.7M Buy
364,578
+16,807
+5% +$4.62M 1.25% 18
2018
Q3 		$95.3M Buy
347,771
+127,121
+58% +$33M 1.06% 22
2018
Q2 		$52.5M Buy
220,650
+81,786
+59% +$18.9M 0.72% 42
2018
Q1 		$30.5M Sell
138,864
-64,749
-32% -$15.2M 0.47% 60
2017
Q4 		$45.8M Buy
203,613
+98,203
+93% +$20.9M 0.76% 39
2017
Q3 		$20M Hold
105,410
– – 0.41% 70
2017
Q2 		$19.8M Buy
105,410
+9,636
+10% +$1.73M 0.48% 53
2017
Q1 		$15.8M Buy
95,774
+94,386
+6,800% +$15M 0.43% 58
2016
Q4 		$200K Sell
1,388
-87,141
-98% -$11.7M 0.01% 213
2016
Q3 		$11.1M Buy
88,529
+20,329
+30% +$2.62M 0.31% 94
2016
Q2 		$8.96M Buy
68,200
+66,812
+4,814% +$9.14M 0.24% 119
2016
Q1 		$193K Hold
1,388
– – ﹤0.01% 225
2015
Q4 		$194K Buy
1,388
+42
+3% +$5.79K ﹤0.01% 209
2015
Q3 		$188K Hold
1,346
– – 0.01% 222
2015
Q2 		$221K Sell
1,346
-47,428
-97% -$7.58M 0.01% 215
2015
Q1 		$7.54M Buy
48,774
+14,125
+41% +$2.01M 0.3% 85
2014
Q4 		$4.36M Buy
34,649
+24,851
+254% +$3.07M 0.17% 120
2014
Q3 		$1.17M Buy
+9,798
New +$1.12M 0.06% 157

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Artemis Investment Management's ELV Position: Q1 2025 in Review

Artemis Investment Management sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 23,290 shares — an estimated $8.59M sold.

Artemis Investment Management first reported a position in ELV in Q3 2014 and held it in 42 quarters. The position peaked at $268M in Q1 2022. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Artemis Investment Management reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Artemis Investment Management sold 23,290 Elevance Health shares in Q1 2025, an estimated $8.59M.
  • Artemis Investment Management first reported a position in Elevance Health in Q3 2014 and held it in 42 quarters.
  • Artemis Investment Management's Elevance Health position peaked at $268M in Q1 2022.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Artemis Investment Management's 13F filing for Q1 2025, filed 24 Apr 2025.